|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
|
|
SIDE EFFECTS:
|
|
Dysmenorrhea |
|
epistaxis |
|
musculoskeletal pain |
|
sinusitis |
|
upper respiratory tract infection |
|
viral infections |
|
Asthma |
|
bronchitis |
|
chest pain |
|
conjunctivitis |
|
earache |
|
Nasal or oral candidiasis |
|
nasal ulcers |
|
Cough |
|
headache |
|
pharyngitis |
|
Arthralgia or myalgia |
|
diarrhea |
|
dyspepsia |
|
nasal burning or irritation |
|
nausea |
|
rhinitis |
|
sneezing |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Cataracts |
|
Glaucoma |
|
Hepatic function impairment |
|
Renal function impairment |
|
>> Infections, fungal, bacterial, or systemic viral |
|
Intolerance to mometasone furoate or other corticosteroids |
|
Nasal septal ulcers, recent |
|
Nasal surgery, recent |
|
Nasal trauma, recent |
|
>> Ocular herpes simplex |
|
Sensitivity to any ingredient in the product , such as benzalkonium chloride, carboxymethylcellulose sodium, citric acid, glycerin, microcrystalline cellulose, phenylethyl alcohol, polysorbate 80, or sodium citrate |
|
>> Tuberculosis, latent or active, of respiratory tract |
|
|
ADULT DOSE:
|
|
Rhinitis, perennial allergic (treatment) or
Rhinitis, seasonal allergic (prophylaxis) or
Rhinitis, seasonal allergic (treatment) -
Nasal, 100 mcg (0.1 mg) (2 metered sprays) in each nostril once a day (total daily dose 200 mcg [0.2 mg]) .
[Sinusitis (treatment adjunct) ]-
Nasal, 100 mcg (0.1 mg)(2 metered sprays) in each nostril twice a day (total daily dose 400 mcg [0.4 mg]. |
|
MAXIMUM ADULT DOSE:
|
|
Rhinitis, perennial allergic (treatment) or
Rhinitis, seasonal allergic (prophylaxis) or
Rhinitis, seasonal allergic (treatment)-
200 mcg (0.2 mg) (4 sprays-2 sprays administered in each nostril) per day
[Sinusitis (treatment adjunct) ]-
800 mcg (0.8 mg) 4 sprays in each nostril twice a day. |
|
PEDIATRIC DOSE:
|
|
Rhinitis, perennial allergic (treatment) or
Rhinitis, seasonal allergic (prophylaxis) or
Rhinitis, seasonal allergic (treatment) -
For children up to 12 years of age: Safety and efficacy have not been established [3 to 11 years of age: 50 mcg (0.05 mg) (1 metered spray) in each nostril once daily(total daily dose 100 mcg [0.1 mg]). ].
For children 12 years of age and older: See Usual adult and adolescent dose .
[Sinusitis (treatment adjunct) ]-
For children below the age of 12: Safety and efficacy have not been established.
For children 12 years of age and older: See Usual adult and adolescent dose . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|